Open original FDA record ↗Recall record
- FDA identifier
- Z-2883-2020
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Aug 24, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The oxygen sensor for certain CARESCAPE R860 devices has a potential issue that may result in an inaccurate display of FiO2 value from what is being delivered.
Source facts
- Action
- On July 14th, 2020 the firm, GE Healthcare, sent an "URGENT MEDICAL DEVICE CORRECTION" letter dated 7/14/2020 to its customers with the following instructions: Safety Instructions You may continue to use the CARESCAPE R860 Ventilator. Ensure that the FiO2 alarm limit is set to the factory default limit +/- 6 % so that the clinician is aware if the measured value differs from set value. When making an extubation decision, use the set FiO2 value instead of the FiO2 measured by the oxygen sensor. The user can use other methods to measure FiO2 or switch to another device and call GE Healthcare. Product Correction: GE Healthcare will correct all affected units at no cost to you. A GE Healthcare representative will contact you to arrange for the correction. Contact Information: If you have any questions or concerns regarding this notification, please contact GE Healthcare Service at 1-800-437-1171 or your local Service Representative.
- Initiated
- 2020-07-14
- Root cause
- Process control
- Terminated
- 2024-09-23
- Distribution
- Domestic Distribution: USA International Distribution: Australia, Bahrain, Bermuda, Canada, Egypt, France, Germany, Honduras, India, Iraq, Italy, Lebanon, Mexico, Panama, Peru, Russia, Saudi Arabia, Singapore, South Africa, Spain, Taiwan and United Arab Emirates.
- Recall number
- Z-2883-2020
- Recall status
- Terminated
- CDRH record ID
- 182672
- FDA classified
- 2020-08-24
- Recall event number
- 86107